Solugen
Brian Fisher has a diverse work experience spanning multiple roles and institutions. Brian began their career as an Undergraduate Research Assistant at Indiana University Bloomington in 2010. Then, they worked as a Graduate Research Assistant at the University of Wisconsin-Madison from 2011 to 2016, where they focused on peptide synthesis, solution-phase folding, and molecular dynamics. Following that, they served as an NIH Postdoctoral Fellow at The University of Chicago from 2016 to 2018, applying bioinformatics and automation platforms to study halogenase biocatalysts. Brian then continued their postdoctoral research as an NIH Postdoctoral Fellow at Indiana University Bloomington from 2018 to 2020. Currently, since 2020, Brian is at Solugen, where they have held the positions of Senior Scientist and currently serves as the Principal Scientist. At Solugen, their work involves optimizing expression systems, genome mining, enzyme modeling, and developing web-based applications for data processing and visualization.
Brian Fisher's education history begins in 2007 when they enrolled at Indiana University Bloomington. From 2007 to 2011, they pursued a Bachelor of Science (B.S.) degree in Biochemistry and a Bachelor of Arts (B.A.) degree in East Asian Languages and Culture with a focus on Japanese.
After completing their undergraduate studies, they joined the University of Wisconsin-Madison in 2011. Brian remained there until 2016, during which they obtained a Doctor of Philosophy (Ph.D.) degree in Organic Chemistry.
This person is not in the org chart
Solugen
2 followers
Solugen is a venture-backed biotech startup that produces high-performance chemicals from plant-derived substitutes. Our award-winning hydrogen peroxide technology was developed in-house by a team of doctors, scientists, and engineers from MIT. Solugen is a manufacturer and supplier of registered biocides and specialty bio-based solutions for divalent control in process flow assurance and asset integrity. We challenge the traditional approach to chemicals production, which is capital intensive, dangerous, environmentally unfriendly and largely unchanged since 1942. Our patented approach takes advantage of bio-inspired reactions to use plant material as a low-cost feedstock to produce novel products cost-competitive with the competition.